Sugar company EID Parry (India) declares Q3FY22 result: The revenue from operations for the quarter ended 31st 'December 2021 was Rs. 686 Crore in comparison to the corresponding quarter of previous year of Rs. 439 Crore. Earnings before . depreciation, interest and taxes (EBITDA) and before exceptional items for the quarter was Rs: 72 Crore in comparison to the corresponding quarter of previous year of Rs. 31 Crore. Standalone Profit after tax for the quarter was Rs. 18 Crore as against Rs. 339 Crore in corresponding quarter of previous year The revenue from operations for the nine months ended 31st December 2021 was Rs. 1,574 Crore in comparison to the corresponding period of previous year of Rs. 1,460 Crore. Earnings before depreciation, interest and taxes (EBITDA) and before exceptional item for the nine months ended 31st December 2021 was Rs. 183 Crore as against Rs. 262 Crore in corresponding period of previous year. Standalone Profit after tax for the nine months ended 31st December 2021 was Rs. 58 Croreas against Rs. 696 Crore in corresponding period of previous year. The consolidated revenue from operations for the quarter ended 31st December 2021 was Rs. 6,529 Crore, registering an increase of 39% in comparison to the corresponding quarter of previous year of Rs. 4,701 Crore. Earnings before depreciation, interest and taxes (EBITDA) and before exceptional item for the quarter ended 31st December 2021 was Rs. 656 Crore registering an increase of 17% in comparison to the corresponding quarter of previous year of Rs. 559 Crore. Consolidated profit after tax was Rs. 395 Crore compared to Rs. 245 Crore in corresponding quarter of previous year . The consolidated revenue from operations for the nine months ended 31st December 2021 was Rs. 17,862 Crore as against corresponding period ofthe previous year of Rs. 14,679 Crore. Earnings before depreciation, interest and taxes (EBITDA) and before exceptional item for the nine months ended 31st December 2021 was Rs. 1,922 Crore against corresponding period of the previous year of Rs. 1,897 Crore. Consolidated profit after tax was Rs. 1,145 Crore as against Rs. 938 Crore in corresponding period of the previous year. Mr. S Suresh, Managing Director commenting on the standalone results mentioned that "The Company performed better than the corresponding quarter of previous year on account of better realisation and higher volume of exports and alcohol sales. Firming up of global sugar prices helped in higher exports. The debt reduction measures have helped in reduction of finance cost. Cane crush for the Company is expected to be better than previous sugar year. The Company continues to focus on sweating the assets along with cost and cash management. During the quarter the company has disposed the Plant and Machinery in Puducherry unit. Standalone Nutraceuticals division incurred a loss of Rs. 0.85 Crore for the quarter compared to a profit of Rs. 1.67 Crore in the corresponding quarter of previous year due to reduced production on account of inclement weather. However, the Standalone Nutraceuticals segment registered a 24% growth in Profit for the nine months ended 31st December 2021 as compared to the corresponding period of the previous year." Result PDF
Conference Call with EID Parry (India) Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings transcript.
Highlights: The Standalone revenue from operations for the quarter ended 30th September 2021 was Rs. 438 Crore registering a degrowth of 17% as against Rs. 529 Crore in the corresponding quarter of previous year. Earnings before depreciation, interest and taxes (EBITDA) for the quarter ended was Rs. 115 Crore as against Rs. 226 Crore in the corresponding quarter of previous year. During the quarter, the Company received from its subsidiary, Coromandel International Limited, a final dividend of Rs. 99 Crore for the financial year 2020-21 as against Rs. 206 Crore for the corresponding quarter of the previous year. Standalone profit after tax for the quarter was Rs. 73 Crore as against Rs. 131 Crore in the corresponding quarter of previous year. The Standalone revenue from operations for the half year ended 30th September 2021 was Rs. 888 Crore registering a degrowth of 13% as against Rs. 1,021 Crore in the corresponding period of previous year. Earnings before depreciation, interest and taxes (EBITDA) and before exceptional items for the half year ended was Rs. 111 Crore against Rs. 232 Crore in the corresponding period of the previous year. Standalone profit after tax for the half year ended was Rs. 40 Crore against Rs. 357 Crore in the corresponding period of previous year. The profit after tax for the half year ended includes an exceptional item of Rs. Nil in comparison to Rs. 363 Crore in the corresponding period of previous year from sale of 2% stake in Coromandel International Limited. Consolidated performance for the quarter and half year ended 30th September 2021: The consolidated revenue from operations for the quarter ended 30th September 2021 was Rs. 6,978 Crore registering an increase of 20% as against Rs. 5,836 Crore in the corresponding quarter of previous year. Earnings before depreciation, interest and taxes (EBITDA) for the quarter ended 30th September 2021 was Rs. 772 Crore registering a decrease of 13% as against Rs. 890 Crore in the corresponding quarter of previous year. Consolidated profit after tax and non-controlling interest was Rs. 244 Crore compared to Rs. 318 Crore in corresponding quarter of previous year. The consolidated revenue from operations for the half year ended 30th September 2021 was Rs. 11,333 Crore registering an increase of 14% as against Rs. 9,978 Crore in the corresponding period of previous year. Earnings before depreciation, interest and taxes (EBITDA) for the half year ended 30th September 2021 was Rs. 1,266 Crore as against Rs. 1,338 Crore in the corresponding period of previous year. Consolidated profit after tax and non-controlling interest was Rs. 376 Crore compared to Rs. 347 Crore in the corresponding period of previous year. Result PDF
Consolidated performance for the Quarter ended 30th rune 2021: The consolidated revenue from operations for the quarter ended 30th June 2021, was Rs. 4,354 Crore registering an increase of 5% in comparison to the corresponding quarter of previous year of Rs. 4,142 Crore. Earnings before depreciation, interest and taxes (EBITDA) for the quarter ended 30th June 2021 was Rs. 494 Crore registering an increase of 10% in comparison to the corresponding quarter of previous year profit of Rs. 448 Crore. Consolidated profit after tax and non-controlling interest was Rs. 133 Crore compared to Rs. 29 Crore in the corresponding quarter of previous year. Standalone performance for the quarter ended 30th rune 2021: The Standalone revenue from operations for the quarter ended 30th June 2021 was Rs. 450 Crore in comparison to the corresponding quarter of previous year of Rs. 491 Crore. Loss before depreciation, interest and taxes (EBITDA) and before exceptional item for the quarter was Rs. 4 Crore compared to a profit of Rs. 6 Crore in corresponding quarter of the previous year. Standalone loss after tax for the quarter was Rs. 33 Crore as against a profit of Rs. 226 Crore in the corresponding quarter of previous year. Sugar Division: The Consolidated Sugar operations reported an operating loss of Rs: 52 Crore (corresponding quarter of previous year: loss of Rs. 29 Crore) fodhe quarter. Farm Inputs Division The Consolidated Farm Inputs operations reported an operating profit ofRs. 481 Crore (corresponding quarter of previous year: profit of Rs: 424 Crore) for the quarter. Nutraceuticals Division For the quarter, Nutraceuticals Division registered a Loss before Interest and Tax of Rs. 0.43 Crore (corresponJiing quarter of previous year: loss of Rs. 3.39 Crore). Mr. S. Suresh, Managing Director commenting on the standalone results mentioned that ; "The Company's operating performance in Q1 2021-22 was almost in line with the performance of corresponding quarter of the previous year as sugar prices remained muted for the quarter. The debt reduction measures have helped in reduction of finance cost. During the quarter sugar prices continued to be under severe pressure due to the carryover surplus, higher sugar production in the country and release order mechanism. Industry is expecting an increase in MSP for Sugar which is long overdue. We were able to export around 36,500 MT under the MAEQ scheme which also helped in better cash flow and profitability. The Company has commenced the operations of 60 KLPD Bagalkot Distillery project at the end of the quarter. Standalone Nutraceuticals business registered a strong performance during the quarter with a 44% . percentage increase in Revenue compared with the corresponding quarter of the previous year from Rs. 14 Crore to Rs. 20 Crore and a 176% percentage increase in profits. The Consolidated Nutraceutical Operations registered a Loss before Interest and TaX of Rs. 0.43 Crore (corresponding quarter of previous year: loss of Rs. 3.39 Crore). This was mainly due to expenses incurred for the B2C launch in the US." Result PDF